Effect of Saccharomyces Boulardii Cell Wall Extracts on Colon Cancer Prevention in Male F344 Rats Treated with 1,2-Dimethylhydrazine

References

• Canadian Cancer Society's Advisory, Committee on Cancer Statistics, Canadian Cancer Statistics 2015: Canadian Cancer Statistics 2014. Toronto, ON, 2014.
   Google Scholar
• Canadian Digestive Health Foundation: Colon Cancer Overview, 2016.
   Google Scholar
• Haggar FA, Boushey RP: Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 22, 191–197, 2009. doi:10.1055/s-0029-1242458
   PubMedGoogle Scholar
• Stevens RG, Swede H, Rosenberg DW: Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies. Cancer Lett 252, 171–183, 2007. doi:10.1016/j.canlet.2006.11.009
   PubMed Web of Science ®Google Scholar
• Gill CI, Rowland IR: Diet and cancer: assessing the risk. Br J Nutr 88, Suppl 1, S73–S87, 2002. doi:10.1079/bjn2002632
   PubMed Web of Science ®Google Scholar
• Klis FM, Mol P, Hellingwerf K, Brul S: Dynamics of cell wall structure in Saccharomyces cerevisiae. FEMS Microbiol Rev 26, 239–256, 2002. doi:10.1111/j.1574-6976.2002.tb00613.x.
   PubMed Web of Science ®Google Scholar
• dos Santos Mathias TR, de Mello PPM, ervulo EFC: Solid wastes in brewing process: a review. J Brew Distilling 5, 1–9, 2014. doi:10.5897/JBD2014.0043.
   Google Scholar
• Dadrass M, Nejati V, Tukmechi A, Hobbenaghi R: The protective effect of cell wall and cytoplasmic fraction of selenium enriched yeast on 1, 2-dimethylhydrazine-induced damage in liver. Res Mol Med 2, 39–45, 2014. doi:10.18869/acadpub.rmm.2.1.39.
   Google Scholar
• Baran J, Allendorf DJ, Hong F, Ross GD: Oral beta-glucan adjuvant therapy converts nonprotective Th2 response to protective Th1 cell-mediated immune response in mammary tumor-bearing mice. Folia Histochem Cytobiol 45, 107–114, 2007.
   PubMed Web of Science ®Google Scholar
• Li B, Cai Y, Qi C, Hansen R, Ding C, et al.: Orally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer. Clin Cancer Res 16, 5153–5164, 2010. doi:10.1158/1078-0432.ccr-10-0820
   PubMed Web of Science ®Google Scholar
• Liu H-Z, Wang Q, He Y: Immunoactivities and antineoplastic activities of Saccharomyces cerevisiae mannoprotein. Carbohydr Polym 83, 1690–1695, 2011. doi:10.1016/j.carbpol.2010.10.026
   Web of Science ®Google Scholar
• Fortin O, Aguilar-Uscanga B, Vu KD, Salmieri S, Lacroix M: Cancer chemopreventive, antiproliferative and superoxide anion scavenging properties of Kluyveromyces marxianus and Saccharomyces cerevisiae var. boulardii cell wall components. Nutr Cancer 70, 83–96, 2018. doi: 10.1080/01635581.2018.1380204.
   Web of Science ®Google Scholar
• Karoui M, Tresallet C, Brouquet A, Radvanyi H, Penna C: [Colorectal carcinogenesis. 2. Underlying epigenetic and genetic alterations and molecular classification of colorectal cancers]. J Chir (Paris) 144, 97–104, 2007. doi:10.1016/S0021-7697(07)89480-4.
   PubMedGoogle Scholar
• Fiala ES: Investigations into the metabolism and mode of action of the colon carcinogens 1,2-dimethylhydrazine and azoxymethane. Cancer 40, 2436–2445, 1977. doi:10.1002/1097-0142(197711)40:5+%3c2436::AID-CNCR2820400908%3e3.0.CO;2-U.
   PubMed Web of Science ®Google Scholar
• Rosenberg DW, Giardina C, Tanaka T: Mouse models for the study of colon carcinogenesis. Carcinogenesis 30, 183–196, 2009. doi:10.1093/carcin/bgn267
   PubMed Web of Science ®Google Scholar
• Ketudat Cairns JR, Esen A: Beta-glucosidases. Cell Mol Life Sci 67, 3389–3405, 2010. doi:10.1007/s00018-010-0399-2
   PubMed Web of Science ®Google Scholar
• Simon GL, Gorbach SL: The human intestinal microflora. Dig Dis Sci 31, 147S–162S, 1986. doi:10.1007/BF01295996.
   PubMed Web of Science ®Google Scholar
• Talalay P: Mechanisms of induction of enzymes that protect against chemical carcinogenesis. Adv Enzyme Regul 28, 237–250, 1989. doi:10.1016/0065-2571(89)90074-5.
   PubMedGoogle Scholar
• Misico RI, Song LL, Veleiro AS, Cirigliano AM, Tettamanzi MC, et al.: Induction of quinone reductase by withanolides. J Nat Prod 65, 677–680, 2002. doi:10.1021/np0106337.
   PubMed Web of Science ®Google Scholar
• Prochaska HJ, Talalay P: Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res 48, 4776–4782, 1988.
   PubMed Web of Science ®Google Scholar
• Li X, Xu X, Ji T, Liu Z, Gu M, et al.: Dietary feeding of Flavokawain A, a Kava chalcone, exhibits a satisfactory safety profile and its association with enhancement of phase II enzymes in mice. Toxicol Rep 1, 2–11, 2014. doi:10.1016/j.toxrep.2014.02.002
   PubMedGoogle Scholar
• Sangeetha N, Viswanathan P, Balasubramanian T, Nalini N: Colon cancer chemopreventive efficacy of silibinin through perturbation of xenobiotic metabolizing enzymes in experimental rats. Eur J Pharmacol 674, 430–438, 2012. doi:10.1016/j.ejphar.2011.11.008
   PubMed Web of Science ®Google Scholar
• Kang YH, Pezzuto JM: Induction of quinone reductase as a primary screen for natural product anticarcinogens. Methods Enzymol 382, 380–414, 2004. doi:10.1016/s0076-6879(04)82021-4
   PubMed Web of Science ®Google Scholar
• Vasiliou V, Ross D, Nebert DW: Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family. Human Genomics 2, 329, 2006. doi:10.1186/1479-7364-2-5-329
   PubMedGoogle Scholar
• Zhu H, Li Y: NAD(P)H: Quinone oxidoreductase 1 and its potential protective role in cardiovascular diseases and related conditions. Cardiovasc Toxicol 12, 39–45, 2012. doi:10.1007/s12012-011-9136-9
   PubMed Web of Science ®Google Scholar
• Siegel D, Gustafson DL, Dehn DL, Han JY, Boonchoong P, et al.: NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol 65, 1238–1247, 2004. doi:10.1124/mol.65.5.1238
   PubMed Web of Science ®Google Scholar
• Talalay P: Chemoprotection against cancer by induction of phase 2 enzymes. Biofactors 12, 5–11, 2000. doi:10.1002/biof.5520120102.
   PubMed Web of Science ®Google Scholar
• Ames BN: Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 221, 1256–1264, 1983. doi:10.1126/science.6351251.
   PubMed Web of Science ®Google Scholar
• Desrouillères K, Millette M, Vu KD, Touja R, Lacroix M: Cancer preventive effects of a specific probiotic fermented milk containing Lactobacillus acidophilus CL1285, L. casei LBC80R and L. rhamnosus CLR2 on male F344 rats treated with 1,2-dimethylhydrazine. J Funct. Foods 17, 816–827, 2015. doi:10.1016/j.jff.2015.06.035
   Web of Science ®Google Scholar
• Bird RP: Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93, 55–71, 1995. doi:10.1016/0304-3835(95)03788-x
   PubMed Web of Science ®Google Scholar
• Prochaska HJ, Santamaria AB: Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. Anal Biochem 169, 328–336, 1988. doi:10.1016/0003-2697(88)90292-8
   PubMed Web of Science ®Google Scholar
• Park HY, Bae EA, Han MJ, Choi EC, Kim DH: Inhibitory effects of Bifidobacterium spp. isolated from a healthy Korean on harmful enzymes of human intestinal microflora. Arch Pharm Res 21, 54–61, 1998. doi:10.1007/BF03216753.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Shimada R, Matsuyama A, Yuasa M, Sawamura H, et al.: Antitumor activity of the beta-glucan paramylon from Euglena against preneoplastic colonic aberrant crypt foci in mice. Food Funct 4, 1685–1690, 2013. doi:10.1039/c3fo60256g
   PubMed Web of Science ®Google Scholar
• Lahouar L, Pochart P, Salem HB, El Felah M, Mokni M, et al.: Effect of dietary fibre of barley variety ‘Rihane’ on azoxymethane-induced aberrant crypt foci development and on colonic microbiota diversity in rats. Br J Nutr 108, 2034–2042, 2012. doi:10.1017/s0007114512000219
   PubMed Web of Science ®Google Scholar
• Bobek P, Galbavy S: Effect of pleuran (beta-glucan from Pleurotus ostreatus) on the antioxidant status of the organism and on dimethylhydrazine-induced precancerous lesions in rat colon. Br J Biomed Sci 58, 164–168, 2001.
   PubMed Web of Science ®Google Scholar
• Stier H, Ebbeskotte V, Gruenwald J: Immune-modulatory effects of dietary Yeast Beta-1,3/1,6-D-glucan. Nutr J 13, 38, 2014. doi:10.1186/1475-2891-13-38
   PubMed Web of Science ®Google Scholar
• Chan GC, Chan WK, Sze DM: The effects of beta-glucan on human immune and cancer cells. J Hematol Oncol 2, 25, 2009. doi:10.1186/1756-8722-2-25
   PubMed Web of Science ®Google Scholar
• Bland EJ, Keshavarz T, Bucke C: The influence of small oligosaccharides on the immune system. Carbohydr Res 339, 1673–1678, 2004. doi:10.1016/j.carres.2004.05.009
   PubMed Web of Science ®Google Scholar
• Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, et al.: Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608–611, 2009. doi:10.1038/nature07602
   PubMed Web of Science ®Google Scholar
• Cuendet M, Oteham CP, Moon RC, Pezzuto JM: Quinone reductase induction as a biomarker for cancer chemoprevention. J Nat Prod 69, 460–463, 2006. doi:10.1021/np050362q
   PubMed Web of Science ®Google Scholar
• Samuelsen AB, Schrezenmeir J, Knutsen SH: Effects of orally administered yeast-derived beta-glucans: a review. Mol Nutr Food Res 58, 183–93, 2014. doi:10.1002/mnfr.201300338
   PubMed Web of Science ®Google Scholar
• Driscoll M, Hansen R, Ding C, Cramer DE, Yan J: Therapeutic potential of various beta-glucan sources in conjunction with anti-tumor monoclonal antibody in cancer therapy. Cancer Biol Ther 8, 218–225, 2009. doi:10.4161/cbt.8.3.7337.
   PubMed Web of Science ®Google Scholar
• Lehne G, Haneberg B, Gaustad P, Johansen PW, Preus H, et al.: Oral administration of a new soluble branched beta-1,3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers. Clin Exp Immunol 143, 65–9, 2006. doi:10.1111/j.1365-2249.2005.02962.x
   PubMed Web of Science ®Google Scholar
• Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, et al.: Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol 173, 797–806, 2004. doi:10.4049/jimmunol.173.2.797.
   PubMed Web of Science ®Google Scholar
• Rice PJ, Adams EL, Ozment-Skelton T, Gonzalez AJ, Goldman MP, et al.: Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J Pharmacol Exp Ther 314, 1079–1086, 2005. doi:10.1124/jpet.105.085415
   PubMed Web of Science ®Google Scholar
• Dabek M, McCrae SI, Stevens VJ, Duncan SH, Louis P: Distribution of beta-glucosidase and beta-glucuronidase activity and of beta-glucuronidase gene gus in human colonic bacteria. FEMS Microbiol Ecol 66, 487–495, 2008. doi:10.1111/j.1574-6941.2008.00520.x
   PubMed Web of Science ®Google Scholar
• Mroczynska M, Galecka M, Szachta P, Kamoda D, Libudzisz Z, et al.: Beta-glucuronidase and Beta-glucosidase activity in stool specimens of children with inflammatory bowel disease. Pol J Microbiol 62, 319–325, 2013.
   PubMed Web of Science ®Google Scholar
• de Moreno de LeBlanc A, Perdigon G: Reduction of beta-glucuronidase and nitroreductase activity by yoghurt in a murine colon cancer model. Biocell 29, 15–24, 2005.
   PubMed Web of Science ®Google Scholar
• Nakamura J, Kubota Y, Miyaoka M, Saitoh T, Mizuno F, et al.: Comparison of four microbial enzymes in Clostridia and Bacteroides isolated from human feces. Microbiol Immunol 46, 487–490, 2002. doi:10.1111/j.1348-0421.2002.tb02723.x.
   PubMed Web of Science ®Google Scholar
• Shen RL, Dang XY, Dong JL, Hu XZ: Effects of oat beta-glucan and barley beta-glucan on fecal characteristics, intestinal microflora, and intestinal bacterial metabolites in rats. J Agric Food Chem 60, 11301–11308, 2012. doi:10.1021/jf302824h
   PubMed Web of Science ®Google Scholar
• McBain AJ, Macfarlane GT: Ecological and physiological studies on large intestinal bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites. J Med Microbiol 47, 407–416, 1998. doi:10.1099/00222615-47-5-407
   PubMed Web of Science ®Google Scholar
• Tohamy AA, El-Ghor AA, El-Nahas SM, Noshy MM: Beta-glucan inhibits the genotoxicity of cyclophosphamide, adriamycin and cisplatin. Mutat Res 541, 45–53, 2003. doi:10.1016/S1383-5718(03)00184-0.
   PubMed Web of Science ®Google Scholar
• Tsiapali E, Whaley S, Kalbfleisch J, Ensley HE, Browder IW, et al.: Glucans exhibit weak antioxidant activity, but stimulate macrophage free radical activity. Free Radic Biol Med 30, 393–402, 2001. doi:10.1016/S0891-5849(00)00485-8.
   PubMed Web of Science ®Google Scholar
• Okamoto T, Kodoi R, Nonaka Y, Fukuda I, Hashimoto T, et al.: Lentinan from shiitake mushroom (Lentinus edodes) suppresses expression of cytochrome P450 1A subfamily in the mouse liver. Biofactors21, 407–409, 2004. doi:10.1002/biof.552210180.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell 144, 646–674, 2011. doi:10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar